Author: Gavioli, Elizabeth M; Sikorska, Gabriela; Man, Ammy; Rana, Jay; Vider, Etty
Title: Current Perspectives of Anticoagulation in Patients with COVID-19. Cord-id: 05y57i8u Document date: 2020_6_5
ID: 05y57i8u
Snippet: Thromboembolism and myocardial injury are common in COVID-19 patients. Low molecular weight heparin appears to be associated with good prognosis in COVID-19 patients and has the ability to reduce coagulation and inflammation markers. Hospitalized COVID-19 patients should be placed on thromboprophylaxis with the option of full-therapeutic anticoagulation or tissue plasminogen activator (tPA) in high risk or mechanically ventilated patients. Thromboprophylaxis should also be considered at hospital
Document: Thromboembolism and myocardial injury are common in COVID-19 patients. Low molecular weight heparin appears to be associated with good prognosis in COVID-19 patients and has the ability to reduce coagulation and inflammation markers. Hospitalized COVID-19 patients should be placed on thromboprophylaxis with the option of full-therapeutic anticoagulation or tissue plasminogen activator (tPA) in high risk or mechanically ventilated patients. Thromboprophylaxis should also be considered at hospital discharge for high risk patients. Clinical judgment should be utilized to evaluate the bleeding and safety risk of anticoagulation in COVID-19 patients without confirmed data.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date